• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前总血清胆固醇与接受切除的非小细胞肺癌患者的生存率

Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer.

作者信息

Tomita Masaki, Ayabe Takanori, Shimizu Tetsuya, Nakamura Kunihide

机构信息

Department of Surgery II, Faculty of Medicine, University of Miyazaki, Kihara 5200, Kiyotake, Miyazaki 889-1692, Japan.

出版信息

Lung Cancer Int. 2012;2012:463520. doi: 10.1155/2012/463520. Epub 2012 Nov 26.

DOI:10.1155/2012/463520
PMID:26316934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4437391/
Abstract

The association between hypocholesterolemia and lung cancer risk has been confirmed in some studies. The purpose of the study was to determine whether preoperative hypocholesterolemia (below normal range) is a prognostic factor for survival after nonsmall cell lung cancer (NSCLC) resection. Two hundred and sixty-two consecutive cases of resected NSCLC with a followup period for more than 5 years were reviewed retrospectively. In our results, there were only 13/262 patients having hypocholesterolemia. A significant association was observed between preoperative hypocholesterolemia and patients' survival. However, we failed to find the prognostic significance of preoperative hypocholesterolemia by univariate analysis. No statistical differences were also found by the comparison between 5-year survivors and the others. Our data indicates a trend toward an association between preoperative hypocholesterolemia and poorer survival in NSCLC; however, it did not reach statistical significance.

摘要

一些研究已证实低胆固醇血症与肺癌风险之间的关联。本研究的目的是确定术前低胆固醇血症(低于正常范围)是否是非小细胞肺癌(NSCLC)切除术后生存的预后因素。回顾性分析了262例连续切除的NSCLC患者,随访期超过5年。在我们的研究结果中,262例患者中仅有13例存在低胆固醇血症。术前低胆固醇血症与患者生存之间存在显著关联。然而,单因素分析未发现术前低胆固醇血症的预后意义。5年生存者与其他患者之间的比较也未发现统计学差异。我们的数据表明术前低胆固醇血症与NSCLC患者较差的生存率之间存在关联趋势;然而,未达到统计学意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a866/4437391/917bb7dbf139/LCI2012-463520.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a866/4437391/917bb7dbf139/LCI2012-463520.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a866/4437391/917bb7dbf139/LCI2012-463520.001.jpg

相似文献

1
Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer.术前总血清胆固醇与接受切除的非小细胞肺癌患者的生存率
Lung Cancer Int. 2012;2012:463520. doi: 10.1155/2012/463520. Epub 2012 Nov 26.
2
An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.术前贫血与接受单纯手术治疗的早期非小细胞肺癌患者生存率降低之间的关联。
Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1438-43. doi: 10.1016/j.ijrobp.2004.12.038.
3
Prognostic significance of p53 and ras p21 expression in nonsmall cell lung cancer.p53和ras p21表达在非小细胞肺癌中的预后意义
Cancer. 1995 Dec 15;76(12):2457-63. doi: 10.1002/1097-0142(19951215)76:12<2457::aid-cncr2820761209>3.0.co;2-x.
4
Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.术前血清肺癌6水平在非小细胞肺癌中的预后意义
Gen Thorac Cardiovasc Surg. 2016 Nov;64(11):657-661. doi: 10.1007/s11748-016-0706-4. Epub 2016 Aug 11.
5
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.I期非小细胞肺癌。治疗方法与复发模式的多变量分析。
Cancer. 1995 Sep 1;76(5):787-96. doi: 10.1002/1097-0142(19950901)76:5<787::aid-cncr2820760512>3.0.co;2-q.
6
Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.在可切除的非小细胞肺癌中,建立并验证一个独立于 TNM 分期的术前预后指数。
BMC Pulm Med. 2017 Dec 4;17(1):166. doi: 10.1186/s12890-017-0529-9.
7
Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.术前升高的炎症标志物(基于中性粒细胞与淋巴细胞比值和 C 反应蛋白)预测非小细胞肺癌切除术后的不良预后。
Anticancer Res. 2012 Aug;32(8):3535-8.
8
Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer.术前细胞角蛋白19片段(CYFRA 21-1)水平作为切除的非小细胞肺癌的预后指标
Eur Respir J. 1998 Dec;12(6):1424-8. doi: 10.1183/09031936.98.12061424.
9
L1CAM-positive expression is associated with poorer survival outcomes in resected non-small cell lung cancer patients.L1细胞粘附分子阳性表达与接受手术切除的非小细胞肺癌患者较差的生存结果相关。
Int J Clin Exp Pathol. 2019 Jul 1;12(7):2665-2671. eCollection 2019.
10
Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma.Ki-67免疫染色及其他预后因素,包括接受手术切除的非小细胞肺癌患者的吸烟情况。
Cancer. 2000 Oct 1;89(7):1457-65. doi: 10.1002/1097-0142(20001001)89:7<1457::aid-cncr7>3.0.co;2-l.

引用本文的文献

1
The CONUT score is prognostic in esophageal cancer treated with chemoradiotherapy.CONUT 评分对接受放化疗的食管癌具有预后价值。
Saudi J Gastroenterol. 2023 Mar-Apr;29(2):119-126. doi: 10.4103/sjg.sjg_384_22.
2
Evaluation of Predictive Values of Naples Prognostic Score in Patients with Unresectable Stage III Non-Small Cell Lung Cancer.那不勒斯预后评分对不可切除的 III 期非小细胞肺癌患者的预测价值评估
J Inflamm Res. 2021 Nov 23;14:6129-6141. doi: 10.2147/JIR.S341399. eCollection 2021.
3
Preoperative controlling nutritional status (CONUT) is useful to estimate the prognosis after esophagectomy for esophageal cancer.

本文引用的文献

1
Small interfering RNA against transcription factor STAT6 leads to increased cholesterol synthesis in lung cancer cell lines.小干扰 RNA 靶向转录因子 STAT6 可导致肺癌细胞系中胆固醇合成增加。
PLoS One. 2011;6(12):e28509. doi: 10.1371/journal.pone.0028509. Epub 2011 Dec 5.
2
Preoperative total serum cholesterol as a prognostic factor for survival in patients with resectable non-small-cell lung cancer.术前总血清胆固醇作为可切除非小细胞肺癌患者生存的预后因素。
Wien Klin Wochenschr. 2009;121(9-10):314-7. doi: 10.1007/s00508-009-1169-8.
3
Do the cholesterol-lowering properties of statins affect cancer risk?
术前控制营养状况(CONUT)有助于评估食管癌切除术后的预后。
Langenbecks Arch Surg. 2017 Mar;402(2):333-341. doi: 10.1007/s00423-017-1553-1. Epub 2017 Jan 30.
他汀类药物的降胆固醇特性会影响癌症风险吗?
Trends Endocrinol Metab. 2008 May-Jun;19(4):113-21. doi: 10.1016/j.tem.2007.12.004. Epub 2008 Mar 20.
4
STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells.STAT6特异性短发夹RNA抑制结肠癌HT-29细胞的增殖并诱导其凋亡。
Cancer Lett. 2006 Nov 8;243(1):38-46. doi: 10.1016/j.canlet.2005.11.020. Epub 2006 Jan 4.
5
Immune system differences in men with hypo- or hypercholesterolemia.
Clin Immunol Immunopathol. 1997 Aug;84(2):145-9. doi: 10.1006/clin.1997.4382.
6
Low plasma cholesterol predicts an increased risk of lung cancer in elderly women.
Prev Med. 1995 Nov;24(6):557-62. doi: 10.1006/pmed.1995.1089.
7
Serum cholesterol and cancer in the NHANES I epidemiologic followup study. National Health and Nutrition Examination Survey.
Lancet. 1987 Aug 8;2(8554):298-301. doi: 10.1016/s0140-6736(87)90890-7.
8
Cancer incidence and cancer mortality in relation to serum cholesterol.
J Natl Cancer Inst. 1989 Dec 20;81(24):1917-21. doi: 10.1093/jnci/81.24.1917.
9
Plasma cholesterol concentration and mortality. The Whitehall Study.血浆胆固醇浓度与死亡率。白厅研究。
JAMA. 1992 Jan 1;267(1):70-6.
10
Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.多重危险因素干预试验中男性受试者的血清胆固醇水平与死亡率研究结果。多重危险因素干预试验研究组
Arch Intern Med. 1992 Jul;152(7):1490-500.